The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA
- PMID: 7927504
- PMCID: PMC1414811
The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA
Abstract
In contrast to antigen-antibody complexes containing native human IgA, solid-phase-deposited IgA activates the alternative complement pathway and binds C3b. To investigate the role of carbohydrate chains in this, various human IgA preparations were treated with neuraminidase alone or together with N-glycanase or O-glycanase, or with mixed glycosidases from the oral bacterium, Streptococcus mitis. Depletion of oligosaccharides was determined by carbohydrate analysis. Removal of sialic acid and N-linked glycan chains greatly increased the C3b-fixing properties of normal serum IgA1 and IgA2. Myeloma IgA1 and IgA2 proteins and secretory IgA had higher C3b-binding activity than normal serum IgA, and this was further increased by removal of sialic acid and N-linked glycans. Fc alpha and Fc alpha-SC fragments of myeloma and secretory IgA1, respectively, but not Fab alpha fragments, obtained by cleavage with bacterial IgA1 proteases and also free secretory component, fixed C3b by the alternative pathway.
Similar articles
-
All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone.Scand J Immunol. 1994 Mar;39(3):275-80. doi: 10.1111/j.1365-3083.1994.tb03371.x. Scand J Immunol. 1994. PMID: 8128187
-
Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation.Eur J Immunol. 1989 Dec;19(12):2243-9. doi: 10.1002/eji.1830191210. Eur J Immunol. 1989. PMID: 2606139
-
Resistance of normal serum IgA and secretory IgA to bacterial IgA proteases: evidence for the presence of enzyme-neutralizing antibodies in both serum and secretory IgA, and also in serum IgG.Microbiol Immunol. 1987;31(11):1097-106. doi: 10.1111/j.1348-0421.1987.tb01341.x. Microbiol Immunol. 1987. PMID: 3127662
-
Secretory immunity and the bacterial IgA proteases.Rev Infect Dis. 1981 May-Jun;3(3):521-34. doi: 10.1093/clinids/3.3.521. Rev Infect Dis. 1981. PMID: 6792682 Review.
-
[Immunoglobulin A and renal diseases].Vnitr Lek. 2006 Mar;52(3):256-62. Vnitr Lek. 2006. PMID: 16722157 Review. Czech.
Cited by
-
Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.J Clin Invest. 1999 Jul;104(1):73-81. doi: 10.1172/JCI5535. J Clin Invest. 1999. PMID: 10393701 Free PMC article.
-
Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.Springer Semin Immunopathol. 1997;18(3):371-90. doi: 10.1007/BF00813504. Springer Semin Immunopathol. 1997. PMID: 9089955 Review. No abstract available.
-
Impact of the molecular form of immunoglobulin A on functional activity in defense against Streptococcus pneumoniae.Infect Immun. 2007 Apr;75(4):1801-10. doi: 10.1128/IAI.01758-06. Epub 2007 Jan 29. Infect Immun. 2007. PMID: 17261616 Free PMC article.
-
Elevated free secretory component in early rheumatoid arthritis and prior to arthritis development in patients at increased risk.Rheumatology (Oxford). 2020 May 1;59(5):979-987. doi: 10.1093/rheumatology/kez348. Rheumatology (Oxford). 2020. PMID: 31504979 Free PMC article.
-
Oral pre-administration of Purslane polysaccharides enhance immune responses to inactivated foot-and-mouth disease vaccine in mice.BMC Vet Res. 2019 Jan 25;15(1):38. doi: 10.1186/s12917-019-1782-3. BMC Vet Res. 2019. PMID: 30683105 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous